Spravato™ is a prescription medication that is FDA-approved for Treatment Resistant Depression in adults. It is administered through the nose. The medication must be taken concomitantly with an oral anti-depressant. In addition, patients must have a history of at least two failed anti-depressant medications.
Spravato™ must be administered in a doctor’s office. The entire procedure lasts at least two hours per the administration guidelines. Administration typically occurs according to a dosing schedule outlined by the drug manufacturer.
Spravato™ is a patented isomer of generic racemic ketamine that is typically used for IV infusions.
Click here to learn more about the medication and procedure